Canada Food & Drug Retailing

PharmaCorp Rx Inc (PCRX)

Track

Track

PharmaCorp Rx Inc. recorded six insider trading transactions over the past ninety days, all representing open market purchases. Five distinct insiders acquired shares totaling 274,616 CAD. This activity follows a positive earnings report where the company beat expectations by 130 percent, despite a 12.7 percent decline in stock price during the same period.
Ticker: PCRX Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for PharmaCorp Rx Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Simpson, Alan Arthur Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
406.91
Quantity 82,475 +49.4%
Value CA$2,334,072
2.2
Hladun, Grant Warren Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
441.02
Quantity 45,004 -6.7%
Value CA$3,864,678
2.2
Dale, Paul Richard Senior Officer of Issuer Officer
Transaction date
Purchase
Price
104.80
Quantity 50,249 -34.5%
Value CA$483,116
2.2
Brown, Grady Douglas Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.51
Quantity 172,942 +19.1%
Value CA$88,200
2.2
Dumont, James Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.51
Quantity 34,706 +11.2%
Value CA$17,700
2.2
Dumont, James Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.51
Quantity 34,706 +9.4%
Value CA$17,700
2.6
Simpson, Alan Arthur Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.42
Quantity 2,380,960 +95.2%
Value CA$1,000,003
2.2
Dumont, James Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.42
Quantity 59,524
Value CA$25,000
2.2
Dumont, James Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.42
Quantity 178,650 +71.5%
Value CA$75,033
2.2
Hladun, Grant Warren Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.42
Quantity 59,500 +11.9%
Value CA$24,990
2.2
Hladun, Grant Warren Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.42
Quantity 71,510
Value CA$30,034
2.2
Dale, Paul Richard Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.42
Quantity 238,100
Value CA$100,002
2.1
Brownell, Kenneth Alva Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.42
Quantity 238,000 +64.0%
Value CA$99,960
2.2
Brown, Grady Douglas Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.42
Quantity 595,240 +190.5%
Value CA$250,001
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-14 B Purchase
2.6
Simpson, Alan Arthur

Director of Issuer

Non-Executive Director
82,475 +49.4%
406.91
CA$2,334,072 		82,475 +49.4% 406.91 CA$2,334,072
2026-07-15 2026-07-14 B Purchase
2.2
Hladun, Grant Warren

Director of Issuer

Non-Executive Director
45,004 -6.7%
441.02
CA$3,864,678 		45,004 -6.7% 441.02 CA$3,864,678
2026-07-15 2026-07-14 B Purchase
2.2
Dale, Paul Richard

Senior Officer of Issuer

Officer
50,249 -34.5%
104.80
CA$483,116 		50,249 -34.5% 104.80 CA$483,116
2026-07-15 2026-07-14 B Purchase
2.2
Brown, Grady Douglas

Director of Issuer

Non-Executive Director
172,942 +19.1%
0.51
CA$88,200 		172,942 +19.1% 0.51 CA$88,200
2026-07-15 2026-07-09 B Purchase
2.2
Dumont, James

Director of Issuer

Non-Executive Director
34,706 +11.2%
0.51
CA$17,700 		34,706 +11.2% 0.51 CA$17,700
2026-07-15 2026-07-09 B Purchase
2.2
Dumont, James

Director of Issuer

Non-Executive Director
34,706 +9.4%
0.51
CA$17,700 		34,706 +9.4% 0.51 CA$17,700
2025-11-14 2025-11-12 B Purchase
2.6
Simpson, Alan Arthur

Director of Issuer

Non-Executive Director
2,380,960 +95.2%
0.42
CA$1,000,003 		2,380,960 +95.2% 0.42 CA$1,000,003
2025-11-14 2025-11-12 B Purchase
2.2
Dumont, James

Director of Issuer

Non-Executive Director
59,524
0.42
CA$25,000 		59,524 0.42 CA$25,000
2025-11-14 2025-11-12 B Purchase
2.2
Dumont, James

Director of Issuer

Non-Executive Director
178,650 +71.5%
0.42
CA$75,033 		178,650 +71.5% 0.42 CA$75,033
2025-11-13 2025-11-12 B Purchase
2.2
Hladun, Grant Warren

Director of Issuer

Non-Executive Director
59,500 +11.9%
0.42
CA$24,990 		59,500 +11.9% 0.42 CA$24,990
2025-11-13 2025-11-12 B Purchase
2.2
Hladun, Grant Warren

Director of Issuer

Non-Executive Director
71,510
0.42
CA$30,034 		71,510 0.42 CA$30,034
2025-11-13 2025-11-12 B Purchase
2.2
Dale, Paul Richard

Senior Officer of Issuer

Officer
238,100
0.42
CA$100,002 		238,100 0.42 CA$100,002
2025-11-13 2025-11-12 B Purchase
2.1
Brownell, Kenneth Alva

Director of Issuer

Non-Executive Director
238,000 +64.0%
0.42
CA$99,960 		238,000 +64.0% 0.42 CA$99,960
2025-11-13 2025-11-12 B Purchase
2.2
Brown, Grady Douglas

Director of Issuer

Non-Executive Director
595,240 +190.5%
0.42
CA$250,001 		595,240 +190.5% 0.42 CA$250,001
Explore more

More insider trading research around PharmaCorp Rx Inc

More insider trades in Canada
Similar Consumer Non-Cyclicals companies with insider activity
More Food & Drug Retailing companies with insider activity
More Food & Drug Retailing companies with insider activity
Insider trading in North America